Choo Chee Kong: insider trades.
Choo Chee Kong reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 4 open-market purchases ($600K) and 0 sales, across 1 company.
- Transactions
- 4
- Purchases (P)
- 4
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Choo Chee Kong
Companies
| Company | Relationship | Transactions |
|---|---|---|
| CytoMed Therapeutics Ltd (GDTC) | Director, TenPercentOwner | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-20 | CytoMed Therapeutics Ltd | P | 100,000 | $1.5 | 630,324 | Form 4 |
| 2026-07-20 | CytoMed Therapeutics Ltd | P | 100,000 | $1.5 | 630,324 | Form 4/A |
| 2026-07-14 | CytoMed Therapeutics Ltd | P | 100,000 | $1.5 | 530,324 | Form 4 |
| 2026-07-14 | CytoMed Therapeutics Ltd | P | 100,000 | $1.5 | 530,324 | Form 4/A |
Questions
What stock did Choo Chee Kong buy or sell?
Choo Chee Kong reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 4 open-market purchases ($600K) and 0 sales, across 1 company.
Is Choo Chee Kong the same person as other filers with this name?
This page covers SEC CIK 1970632 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/choo-chee-kong-1970632.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.